Phase 2 study of HDAC inhibitor tucidinostat in combination with anti-PD-1 antibody in patients with locally advanced or metastatic urothelial carcinoma

被引：0
|
作者：
Liu, Zhuowei
Jiang, Lijuan
Li, Xiangdong
Ye, Yunlin
Wu, Zhiming
An, Xin
Shi, Yanxia
Yao, Kai
机构：
[1] Sun Yat Sen Univ, Canc Ctr, Guangzhou, Peoples R China
[2] Sun Yat Sen Univ, Dept Urol, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China,Canc Ctr, Guangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16563
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Recombinant humanized anti-PD-1 monoclonal antibody toripalimab in patients with metastatic urothelial carcinoma: Preliminary results of an open-label phase II clinical study.
    Sheng, Xinan
    Chen, Haige
    Yao, Xin
    Hu, Yi
    Yao, Xudong
    Liu, Ziling
    Zhou, Fangjian
    Huang, Yiran
    Guo, Jun
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [22] Phase I Study of Androgen Deprivation Therapy in Combination with Anti-PD-1 in Melanoma Patients Pretreated with Anti-PD-1
    Robert, Caroline
    Lebbe, Celeste
    Lesimple, Thierry
    Lundstrom, Eija
    Nicolas, Valerie
    Gavillet, Bruno
    Crompton, Philippa
    Baroudjian, Barouyr
    Routier, Emilie
    Lejeune, Ferdy J.
    CLINICAL CANCER RESEARCH, 2023, 29 (05) : 858 - 865
  • [23] A PHASE 1 STUDY OF SERPLULIMAB (A NOVEL ANTI-PD-1 ANTIBODY) IN COMBINATION WITH HLX04 (AN ANTI-VEGF ANTIBODY) IN PATIENTS WITH ADVANCED SOLID TUMORS.
    Guo, Y.
    Li, J.
    Li, Q.
    Xue, J.
    Xue, L.
    Ge, X.
    Lin, F.
    Zhao, W.
    Tang, W.
    Peng, D.
    Wang, Q.
    Zhu, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 : S29 - S30
  • [24] A phase I study of enfortumab vedotin in Japanese patients with locally advanced or metastatic urothelial carcinoma
    Takahashi, Shunji
    Uemura, Motohide
    Kimura, Tomokazu
    Kawasaki, Yoshihide
    Takamoto, Atsushi
    Yamaguchi, Akito
    Melhem-Bertrandt, Amal
    Gartner, Elaina M.
    Inoue, Takashi
    Akazawa, Rio
    Kadokura, Takeshi
    Tanikawa, Toshiki
    INVESTIGATIONAL NEW DRUGS, 2020, 38 (04) : 1056 - 1066
  • [25] A phase I study of enfortumab vedotin in Japanese patients with locally advanced or metastatic urothelial carcinoma
    Shunji Takahashi
    Motohide Uemura
    Tomokazu Kimura
    Yoshihide Kawasaki
    Atsushi Takamoto
    Akito Yamaguchi
    Amal Melhem-Bertrandt
    Elaina M. Gartner
    Takashi Inoue
    Rio Akazawa
    Takeshi Kadokura
    Toshiki Tanikawa
    Investigational New Drugs, 2020, 38 : 1056 - 1066
  • [26] Immune mediators as predictive biomarkers for anti-PD-1 antibody therapy in urothelial carcinoma
    Shibata, Yosuke
    Kishida, Takeshi
    Kouro, Taku
    Wei, Feifei
    Igarashi, Yuka
    Himuro, Hidetomo
    Noguchi, Takeaki
    Koizumi, Mitsuyuki
    Suzuki, Takahisa
    Osaka, Kimito
    Saigusa, Yusuke
    Sasada, Tetsuro
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [27] A Phase 1 study of fianlimab (anti-LAG-3) in combination with cemiplimab (anti-PD-1) in patients with advanced ccRCC
    Kim, Miso
    ONCOLOGIST, 2024, 29 : S7 - S7
  • [28] A phase 1 study of fianlimab (anti-LAG-3) in combination with cemiplimab (anti-PD-1) in patients with advanced HNSCC
    Cho, Byoung Chul
    Hamid, Omid
    Zhu, Xinhua
    Keam, Bhumsuk
    Kaczmar, John M.
    Williamson, Stephen K.
    Birnbaum, Ariel E.
    Dowlati, Afshin
    Dy, Grace K.
    Hager, Steven Jeffrey
    Lynce, Filipa
    McDermott, Raymond S.
    Sarker, Debashis
    Weise, Amy M.
    Yap, Timothy A.
    Yilmaz, Emrullah
    Fang, Fang
    Mani, Jayakumar
    Kroog, Glenn Scott
    Papadopoulos, Kyriakos P.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [29] Cabozantinib in patients with locally advanced or metastatic urothelial cell carcinoma who have progressed after cisplatin-based chemotherapy and anti-PD-1/PD-L1 therapy or after anti-PD-1/PD-L1 therapy only.
    Bartsch, Georg
    Thomas, Christian
    Tsaur, Igor
    Schnabel, Marco
    Haferkamp, Axel
    Gorbulev, Stanislav
    Ruckes, Christian
    Kronfeld, Kai
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [30] Therapy of the metastatic Merkel Cell Carcinoma with the Anti-PD-1 Antibody Pembrolizumab
    Meier, K.
    Wilhelmi, J.
    Lomberg, D.
    Spaenkuch, I
    Scheu, A.
    Leiter, U.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2017, 15 : 171 - 171
12345